血浆紧缺情况下非生物型人工肝治疗新模式的探讨

李爽; 陈煜

doi:10.3969/j.issn.1001-5256.2017.09.012

血浆紧缺情况下非生物型人工肝治疗新模式的探讨

DOI: 10.3969/j.issn.1001-5256.2017.09.012

李爽,
陈煜

首都医科大学附属北京佑安医院疑难肝病及人工肝中心

基金项目:

国家科技重大专项“艾滋病和病毒性肝炎等重大传染病防治”(2017ZX10203201-005)；北京市医院管理局“登峰”人才培养计划基金资助项目(DFL20151601)；北京卫生系统高技术人才培养项目基金(2013-3-071)；

详细信息

中图分类号: R575.3
计量
- 文章访问数: 2442
- HTML全文浏览量: 39
- PDF下载量: 522
- 被引次数: 0
出版历程
- 收稿日期: 2017-06-23
- 出版日期: 2017-09-20

Coping with shortage of plasma-The new therapeutic pattern of non-bioartificial liver

Li Shuang,
Chen Yu

Artificial Liver Treatment & Training Center, Beijing You'an Hospital, Capital Medical University

Research funding:

摘要

摘要: 随着肝衰竭患者的不断增加,人工肝技术的应用迎来巨大的机遇和挑战。尽管人工肝在肝衰竭患者的治疗中取得了显著成绩,但以血浆置换为代表的国内常用的非生物型人工肝技术面临着严峻的血浆来源受限问题。以血浆置换为中心,从多个角度对非生物型人工肝在治疗中如何应对血浆紧缺情况进行重点探讨,以期为临床医生提供参考。
- 肝功能衰竭 /
- 肝,人工 /
- 血浆置换 /
- 治疗
Abstract: With the increase in patients with liver failure, the artificial liver support system is facing great opportunities and challenges. Although artificial liver has achieved remarkable results in the treatment of patients with liver failure, non-bioartificial liver techniques commonly used in China, mainly plasma exchange, are facing the issue of limited plasma supply. This article focuses on plasma exchange and discusses how to deal with the shortage of plasma in non-bioartificial liver treatment from various aspects, in order to provide a reference for clinical physicians.
- liver failure /
- liver, artificial /
- plasma exchange /
- therapy

HTML全文

参考文献(35)

[1] DUAN ZP, CHEN Y.Clinical application of artificial livers[J].Chin J Hepatol, 2010, 18 (11) :808-810. (in Chinese) 段钟平, 陈煜.人工肝的临床应用[J].中华肝脏病杂志, 2010, 18 (11) :808-810.

[2]NEVENS F, LALEMAN W.Artificial liver support devices as treatment option for liver failure[J].Best Pract Res Clin Gastroenterol, 2012, 26 (1) :17-26.

[3]SHEN Y, WANG XL, WANG B, et al.Survival benefits with artificial liver support system for acute-on-chronic liver failure:a time series-based meta-analysis[J].Medicine, 2016, 95 (3) :e2506.

[4]QIN G, SHAO JG, WANG B, et al.Artificial liver support system improves short-and long-term outcomes of patients with HBV-associated acute-on-chronic liver failure:a single-center experience[J].Medicine, 2014, 93 (28) :e338.

[5]KEKLIK M, SIVGIN S, KAYNAR L, et al.Treatment with plasma exchange may serve benefical effect in patients with severe hyperbilirubinemia:a single center experience[J].Transfus Apher Sci, 2013, 48 (3) :323-326.

[6]CHEN JJ, HUANG JR, YANG Q, et al.Plasma exchange-centered artiifcial liver support system in hepatitis B virus-related acute-on-chronic liver failure:a nationwide prospective multicenter study in China[J].Hepatobiliary Pancreat Dis Int, 2016, 15 (3) :275-281.

[7] Liver Failure and Artificial Liver Group, Branch of Infectious Diseases, Chinese Medical Association.Guideline for non-bioartificial liver support systems in treatment of liver failure:2016 update[J].Chin J Clin Infect Dis, 2016, 9 (2) :97-103. (in Chinese) 中华医学会感染病学分会肝衰竭与人工肝学组.非生物型人工肝治疗肝衰竭指南 (2016年版) [J].中华临床感染病杂志, 2016, 9 (2) :97-103.

[8]XU JZ, DUAN ZP.Practical handbook of artificial liver and blood purification[M].Beijing:China Medical Science Press, 2005:56-58. (in Chinese) 许家璋, 段钟平.实用人工肝及血液净化操作手册[M].北京:中国医药科技出版社, 2005:56-58.

[9]GOU LM.Individual selection for artificial liver support[J].Chin JPrac Intern Med, 2016, 36 (5) :371-375. (in Chinese) 郭利民.人工肝个体化选择[J].中国实用内科杂志, 2016, 36 (5) :371-375.

[10]MCLEOD BC.Therapeutic apheresis:use of human serum albumin, fresh frozen plasma and cryosupernatant plasma in therapeutic plasma exchange[J].Best Pract Res Clin Haematol, 2006, 19 (1) :157-167.

[11]WU Y, WU AS, WANG J, et al.Effects of the novel 6%hydroxyethyl starch 130/0.4 on renal function of recipients in living-related kidney transplantation[J].Chin Med J, 2010, 123 (21) :3079-3083.

[12]HUANG CC, KAO KC, HSU KH, et al.Effects of hydroxyethyl starch resuscitation on extravascular lung water and pulmonary permeability in sepsis-related acute respiratory distress syndrome[J].Critical Care Medicine, 2009, 37 (6) :1948-1955.

[13]SUN C, PENG C, JIE SH, et al.Application of hydroxyethyl starch as plasma expander in ALSS treatment of patients with liver failure and its safety assessment[J].Acta Med Univ Sci Technol Huazhong, 2013, 42 (6) :681-684. (in Chinese) 孙潺, 彭程, 揭盛华, 等.羟乙基淀粉代血浆在人工肝支持系统中治疗肝衰竭的应用及安全性[J].华中科技大学学报:医学版, 2013, 42 (6) :681-684.

[14]MCLEOD BC.Plasma and plasma derivatives in therapeutic plasmapheresis[J].Transfusion, 2012, 52 (Suppl s1) :38s-44s.

[15]AGREDA-VSQUEZ GP, ESPINOSA-POBLANO I, SNCHEZ-GUERRERO SA, et al.Starch and albumin mixture as replacement fluid in therapeutic plasma exchange is safe and effective[J].J Clin Apher, 2008, 23 (5) :163-167.

[16]YE JM, ZHU AF, CHEN H, et al.Clinical effect of part plasma exchanges by different fluid replacement in the treatment of patients with severe hepatitis[J].Chin J Dial Artif Organs, 2013, 24 (1) :17-20. (in Chinese) 叶俊茂, 朱爱芬, 陈红, 等.补充不同置换液进行选择性血浆置换治疗重型肝炎患者的临床效果[J].透析与人工器官, 2013, 24 (1) :17-20.

[17]XU YQ, SHI WM, LI JS, et al.Application of plasma substitute and albumin in plasema exchange therapy of artificial liver support system:a clinical study in liver failure patients[J].Chin J Crit Care Med, 2013, 33 (9) :829-831. (in Chinese) 徐玉琴, 石文明, 李金顺, 等.代血浆加白蛋白置换液部分代替血浆进行人工肝治疗肝衰竭的临床观察[J].中国急救医学, 2013, 33 (9) :829-831.

[18]ZHANG XF, DENG QZ, PANG ZQ, et al.Evaluation of effectiveness and safety of application of 5%albumin on artificial liver selective plasma exchange treatment[J].China Mod Doct, 2016, 54 (13) :27-30. (in Chinese) 张行芬, 邓勤智, 庞中强, 等.5%白蛋白用于人工肝选择性血浆置换治疗的有效性和安全性评价[J].中国现代医生, 2016, 54 (13) :27-30.

[19]LIU X, GUO HQ, ZHANG J, et al.Progress in technology and clinical application of non-bioartificial liver support system[J].JClin Hepatol, 2013, 29 (9) :661-665. (in Chinese) 刘晓慧, 郭海清, 张晶, 等.非生物型人工肝技术及其临床应用新进展[J].临床肝胆病杂志, 2013, 29 (9) :661-665.

[20]MORI T, EGUCHI Y, SHIMIZU T, et al.A case of acute hepatic insufficiency treated with novel plasmapheresis plasma diafiltration for bridge use until liver transplantation[J].Ther Apher, 2002, 6 (6) :463-466.

[21]WANG Y, GUO LM, XIONG HF, et al.Treatment of patients with liver failure using fractional plasma diafiltration:an analysis of 56 cases[J].World Chin J Dig, 2009, 17 (23) :2433-2437. (in Chinese) 王宇, 郭利民, 熊号峰, 等.不同成分血浆滤过透析治疗重型肝炎患者56例[J].世界华人消化杂志, 2009, 17 (23) :2433-2437.

[22]XING HQ, LIU JW, WANG KL, et al.Analysis of clinical effect of continuous plasma diafiltration for the therapy of liver failure[J].BME&Clin Med, 2013, 17 (2) :152-155. (in Chinese) 邢汉前, 刘俊微, 王开利, 等.持续缓慢血浆透析滤过治疗肝功能衰竭的临床疗效分析[J].生物医学工程与临床, 2013, 17 (2) :152-155.

[23]NAKAE H, EGUCHI Y, YOSHIOKA T, et al.Plasma diafiltration therapy in patients with postoperative liver failure[J].Ther Apher Dial, 2011, 15 (4) :406-410.

[24]NAKAE H, EGUCHI Y, SAOTOME T, et al.Multicenter study of plasma diafiltration in patients with acute liver failure[J].Ther Apher Dial, 2010, 14 (5) :444-450.

[25]EGUCHI Y, NAKAE H, FURUYA T, et al.Plasma filtration with dialysis (plasma diafiltration) in critically ill patients with acute liver failure[J].Critical Care, 2014, 18 (1) :399.

[26]KOMURA T, TANIGUCHI T, NODA T, et al.Efficacy of continuous plasma diafiltration therapy[J].Critical Care, 2014, 29 (1) :782-786.

[27]ZHOU PQ, ZHENG SP, YU M, et al.Prognosis of acute-onchronic liver failure patients treated with artificial liver support system[J].World J Gastroenterol, 2015, 21 (32) :9614-9622.

[28]ZHOU J, WAN H, YANG ZM, et al.Clinical effect of plasma perfusion combined with plasma exchange in treatment of patients with acute-on-chronic liver failure[J].J Clin Hepatol, 2017, 33 (4) :715-718. (in Chinese) 周渐, 万红, 杨正茂, 等.血浆灌流联合血浆置换治疗慢加急性肝衰竭的效果观察[J].临床肝胆病杂志, 2017, 33 (4) :715-718.

[29]ZHOU N, LI J, ZHANG Y, et al.Efficacy of coupled low-volume plasma exchange with plasma filtration adsorption in treating pigs with acute liver failure:a randomised study[J].J Hepatol, 2015, 63 (2) :378-387.

[30]GONG D, REN B, JI D, et al.Selective albumin exchange:a novel and simple method to remove bilirubin[J].Int J Artif Organs, 2008, 31 (5) :425-430.

[31]ZHANG B, YANG YG, GONG YF, et al.Clinical application of double plasma molecular adsorption system in treatment of acute liver failure[J].World Chin J Dig, 2015, 23 (29) :4720-4724. (in Chinese) 张斌, 杨永耿, 巩月英, 等.双重血浆分子吸附治疗急性肝衰竭的临床应用[J].世界华人消化杂志, 2015, 23 (29) :4720-4724.

[32]ZHANG BW, YANG XF, LUO XJ, et al.Comparison of clinical effects of double plasma molecular adsorption system, plasma bilirubin adsorption and plasma exchange in liver failure[J].China JModern Med, 2016, 26 (12) :103-106. (in Chinese) 张宝文, 阳学风, 罗湘俊, 等.双重血浆吸附、胆红素吸附及血浆置换治疗肝衰竭的疗效比较[J].中国现代医学杂志, 2016, 26 (12) :103-106.

[33]WAN YM, LI YH, XU ZY, et al.Therapeutic plasma exchange versus double plasma molecular absorption system in hepatitis B virus-infected acute-on-chronic liver failure treated by entercavir:a prospective study[J].J Clin Apher, 2017.[Epub ahead of print]

[34] Liver Failure and Artificial Liver Group, Chinese Society of Infectious Diseases, CMA;Sever Liver Disease and Artificial Liver Group, Chinese Society of Hepatology, CMA.Diagnostic and treatment guidelines for liver failure (2012 version) [J].Chin J Clin Infect Dis, 2012, 5 (6) :321-327. (in Chinese) 中华医学会感染病学分会肝衰竭与人工肝学组, 中华医学会肝病学分会重型肝病与人工肝学组.肝衰竭诊治指南 (2012年版) [J].中华临床感染病杂志, 2012, 5 (6) :321-327.

[35]CERD J, TOLWANI A, GIBNEY N, et al.Renal replacement therapy in special settings:extracorporeal support devices in liver failure[J].Semin Dia, 2011, 24 (2) :197.

施引文献

资源附件(0)

访问统计